Category: Antibodies

Filter By
Categories: Antibody panels Categories: Intracellular Functional Antibodies Clear all
Icrucumab Icrucumab

Icrucumab

Reference: HY-P99364
€0.00 (tax incl.)
Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a humanized Anti-VEGFR-1 IgG1 monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors.
Ieramilimab Ieramilimab

Ieramilimab

Reference: HY-P99027
€0.00 (tax incl.)
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules.
Sudubrilimab Sudubrilimab

Sudubrilimab

Reference: HY-P99963
€0.00 (tax incl.)
Sudubrilimab (HS636) is an Ig G1-kappa monoclonal antibody against PDL1. Sudubrilimab is fused at the C terminus of the heavy chain to a TGF-β1 receptor Ⅱ ectodomain (TGFBR2-ECD), and which can sequester the...
Batiraxcept Batiraxcept

Batiraxcept

Reference: HY-P99463
€0.00 (tax incl.)
Batiraxcept (AVB-S6-500) is a highly potent and specific AXL inhibitor, a recombinant fusion protein dimer containing the extracellular domain of human AXLM and human immunoglobulin G1 heavy chain (Fc). Batiraxcept...
Disitamab Disitamab

Disitamab

Reference: HY-P99854
€0.00 (tax incl.)
Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2. Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs), Disitamab vedotin (Disitamab vedotin (HY-P9985)).
Zampilimab Zampilimab

Zampilimab

Reference: HY-P99512
€0.00 (tax incl.)
Zampilimab (UCB-7858) is a monoclonal antibody against transglutaminase 2 (TG2). Zampilimab has potential application in renal transplant.
CTX-471 CTX-471

CTX-471

Reference: HY-P99178
€0.00 (tax incl.)
CTX-471 is a fully human monoclonal antibody of CD137. CTX-471 has bind affinity for recombinant human, cynomolgus macaque CD137 and mouse CD137 with Kd values of 50 nM, 61 nM and 748 nM, respectively. CTX-471 can be...
Latikafusp Latikafusp

Latikafusp

Reference: HY-P99687
€0.00 (tax incl.)
Latikafusp (AMG 256) is a bifunctional fusion protein comprising a PD-1-targeting antibody and IL-21 mutein designed to deliver IL-21 pathway stimulation to PD-1+ cells. Latikafusp is designed to prime and extend the...
Simtuzumab Simtuzumab

Simtuzumab

Reference: HY-P99047
€0.00 (tax incl.)
Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC).
Orticumab Orticumab

Orticumab

Reference: HY-P99793
€0.00 (tax incl.)
Orticumab (MLDL1278A) is an antibody targeting to oxidized or malondialdehyde-modified lipoprotein (LDL). Orticumab specifically inhibits oxidized low-density lipoproteins (oxLDL). Orticumab involves in modulation of...
Geptanolimab Geptanolimab

Geptanolimab

Reference: HY-P99639
€0.00 (tax incl.)
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research...
Naptumomab Naptumomab

Naptumomab

Reference: HY-P99035
€0.00 (tax incl.)
Naptumomab, a tumor targeting superantigen (TTS), is a fusion protein containing. Naptumomab stimulates the immune system to identify and kill tumour cells. Naptumomab can be used for the research of refractory solid...
Teclistamab Teclistamab

Teclistamab

Reference: HY-P99392
€0.00 (tax incl.)
Teclistamab is a human bispecific antibody to BCMA and CD3 that recognizes BCMA on target cells and CD3 on T cells and induces T cell-mediated cytotoxicity leading to T cell activation and subsequent target cell...
Crovalimab Crovalimab

Crovalimab

Reference: HY-P99965
€0.00 (tax incl.)
Crovalimab (SKY59; RO7112689) is a novel humanized antibody against C5 in a pH-dependent manner with KDs of 15.2 nM and 16.8 μM at pH 7.4 and 5.8, respectively. Crovalimab binds human FcRn with great affinity (KD: 17...
Trastuzumab beta Trastuzumab beta

Trastuzumab beta

Reference: HY-P99548
€0.00 (tax incl.)
Trastuzumab beta (ABP 980) is a biosimilar to Trastuzumab (HY-P9907). Trastuzumab beta is a monoclonal antibody (McAb) targeting human epidermal growth factor receptor 2 (HER2). Trastuzumab beta can be used for the...
Gatipotuzumab Gatipotuzumab

Gatipotuzumab

Reference: HY-P99634
€0.00 (tax incl.)
Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC).
Flanvotumab Flanvotumab

Flanvotumab

Reference: HY-P99622
€0.00 (tax incl.)
Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated...
Inotuzumab Inotuzumab

Inotuzumab

Reference: HY-P99264
€0.00 (tax incl.)
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can...
Temelimab Temelimab

Temelimab

Reference: HY-P99567
€0.00 (tax incl.)
Temelimab (GNbAC-1) is an IgG4 monoclonal antibody that targets the human endogenous retroviral envelope protein HERV-W-Env.
Quisovalimab Quisovalimab

Quisovalimab

Reference: HY-P99810
€0.00 (tax incl.)
Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome...
Adecatumumab Adecatumumab

Adecatumumab

Reference: HY-P99278
€0.00 (tax incl.)
Adecatumumab (Anti-Human EPCAM Recombinant Antibody; MT201) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is...
Perakizumab Perakizumab

Perakizumab

Reference: HY-P99310
€0.00 (tax incl.)
Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis.
Romosozumab Romosozumab

Romosozumab

Reference: HY-P9982
€0.00 (tax incl.)
Romosozumab is a humanized monoclonal anti-sclerostin antibody, it promotes bone formation and inhibits bone resorption by inhibiting sclerostin. Romosozumab can be used for the research of osteoporosis.
Anti-Mouse CD11b Antibody Anti-Mouse CD11b Antibody

Anti-Mouse CD11b Antibody

Reference: HY-P99121
€0.00 (tax incl.)
Anti-Mouse CD11b Antibody is an anti-mouse CD11b IgG2b antibody inhibitor derived from the host Rat.
Tilavonemab Tilavonemab

Tilavonemab

Reference: HY-P99163
€0.00 (tax incl.)
Tilavonemab (ABBV-8E12) is a humanised anti-tau antibody that binds amino acids 25-30 near the N-terminal end of the tau protein. Tilavonemab blocks the ability of human and mouse neurons to take up tau aggregates and...
Cosfroviximab Cosfroviximab

Cosfroviximab

Reference: HY-P99832
€0.00 (tax incl.)
Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP).
Human IgG2 kappa, Isotype Control Human IgG2 kappa, Isotype Control

Human IgG2 kappa, Isotype Control

Reference: HY-P99002
€0.00 (tax incl.)
Human IgG2 kappa, Isotype Control, a human monoclonal antibody, is an isotype control for human IgG2κ antibody.
Seletracetam lithium Seletracetam lithium

Seletracetam lithium

Reference: HY-119810A
€0.00 (tax incl.)
Seletracetam (Ucb 44212) lithium, as an analog of the antiepileptic agent Levetiracetam, is a SV2A modulator for the research of epilepsy.
Ledelabricin alfa Ledelabricin alfa

Ledelabricin alfa

Reference: HY-P99690
€0.00 (tax incl.)
Ledelabricin alfa is a human proteoglycan 4 (PRG4) isoform A variant. PRG4 is a joint/boundary lubricant. Ledelabricin Alfa can be used for the research arthropathy.
Nerelimomab Nerelimomab

Nerelimomab

Reference: HY-P99753
€0.00 (tax incl.)
Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis.
Obiltoxaximab Obiltoxaximab

Obiltoxaximab

Reference: HY-P9932
€0.00 (tax incl.)
Obiltoxaximab is a potent anti-protective antigen (PA) monoclonal antibody. Obiltoxaximab plays a central role in anthrax toxin assembly and target cell intoxication. Obiltoxaximab can be used in animal‐to‐human dose...

Menu

Settings

Please sign in first.

Sign in